Sterile injectable drugs are among the most widely used medicines worldwide with applications ranging from parenteral nutrition to treating a wide range of diseases & conditions. In this article, we will explore some of the latest trends and developments in the sterile injectable drug market that are driving growth across the industry.
By the end of 2024, the cancer segment is projected to reach close to US$ 100 Bn in value, expanding at a CAGR of 6.5% over the forecast period. Revenue from the cancer segment in the global sterile injectable drugs market is expected to increase 1.7X by 2024 end as compared to that in 2016.
Request For Free Sample Report of “Sterile Injectable Drugs Market”@ https://www.persistencemarketresearch.com/samples/12811
Firstly, advancements in technology have led to increasing demand for more complex biologic molecules due to their greater efficacy & lower costs when compared to traditional chemotherapeutic agents; these include monoclonal antibodies, immunotherapies & other targeted therapeutics which can be formulated into injectable formats.
In addition, there have been significant improvements within manufacturing processes such as prefilled syringes – with devices now able to offer more accurate dosage control & improved safety features via advances in design engineering. Furthermore, many companies are now pursuing a ‘closed system’ approach towards production – whereby contaminants can be eliminated or reduced through enhanced sterilization methods & containment strategies prior to packaging.
Companies
- Baxter International Inc.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc.
- AstraZeneca
- GILEAD SCIENCES, INC.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson Services, Inc.
- Nova Nordisk A/S
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12811
Key player strategies in the global sterile injectable drugs market
Companies operating in the global sterile injectable drugs market are striving to consolidate their market position by means of acquiring small and large injectable firms in the market. Companies are also focusing on increasing their manufacturing capacities to achieve greater economies of scale and are concentrating on diverse global markets to improve their geographic foothold in the global sterile injectable drugs market.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/12811
Global Sterile Injectable Drugs Market Segmentation
| By Region |
|
| By Drug Type |
|
| By Application |
|
| By Route of Administration |
|
| By Molecule Type |
|
| By Distribution Channel |
|
Check out more Premium studies published by Persistence Market Research
DNA and RNA Sample Preparation market
Single-Use Bioprocess Systems market
Macular Degeneration Treatment market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353